Interventions for Children and Adolescents With High Body Mass Index
Roohi Y. Kharofa,Nancy A. Crimmins,Amy S. Shah
DOI: https://doi.org/10.1001/jamanetworkopen.2024.18201
2024-06-19
JAMA Network Open
Abstract:The pediatric obesity epidemic continues to assail our nation's youth, with 1 in 5 children and adolescents affected by obesity, based on 2020 data from the Centers for Disease Control and Prevention. 1 Given the metabolic disease burden associated with pediatric obesity, clinical and research endeavors to identify evidence-based interventions continue at a rapid pace. Data regarding intensive lifestyle therapy (ILT), pharmacotherapy, and bariatric surgery interventions 2 ,3 have changed the landscape of treatment for pediatric patients in the past decade. In the past 4 years specifically, we have seen a rapid increase in pharmacotherapy options approved by the US Food and Drug Administration (FDA) for pediatric weight management. As a result, clinicians treating youth with obesity, both in primary and tertiary care, continue to look to professional organizations for how and when to utilize newer therapeutic options. The United States Preventive Services Task Force (USPSTF) reassessed their 2017 recommendations on management of high body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) (≥95th percentile) among children and adolescents. In their updated 2024 statement, the USPSTF reaffirmed the importance of comprehensive ILT targeting pediatric obesity in children aged 6 years and older stating with moderate certainty that these interventions have a moderate net benefit (grade B statement). 4 ,5 Screening for obesity with BMI calculations was removed from recommendation, as it is now a routine part of clinical care. Furthermore, the recommendation reaffirmed the need for contact between patients and ILT practitioners to be frequent, with the data supporting at least 26 contact hours over 3 to 12 months. 4 ,5 The USPSTF found inadequate evidence on the benefits of pharmacotherapy in youth with obesity, encouraging clinicians to use ILT as the primary intervention. 4 ,5 Twenty-six contact hours of ILT equates to weekly, 1-hour sessions for 6 months. 6 The evidence supports that, in general, the more contact hours, the better the weight outcomes. While ILT with at least 26 contact hours is associated with significant improvement in BMI (mean BMI difference,−0.8; 95% CI, −1.2 to −0.4), interventions with at least 52 contact hours are associated with a stronger and more consistent BMI reduction (mean BMI difference, −2.0; 95% CI, −4.0 to −0.1). 4 ,5 Identification of the necessary dose to improve outcomes is tremendously helpful in setting the bar for clinicians and families. However, this number can also be disheartening, given the limited capacity of staff, resources, and funding in clinical programs. How can health care practitioners supplement clinical care to meet this 26-hour threshold? The key may be the physical activity component. The inclusion of physical activity sessions during behavioral intervention studies was associated with significantly greater reductions in BMI, as stated in the USPSTF evidence review. 4 ,5 These sessions varied in frequency (1-2 times per week), intensity, and type. Given the variability in sessions within studies, athletics participation could be prescribed by weight management practitioners to bridge the gap between clinical care and the 26-hour threshold. For those not interested in group sports or hindered by participation fees, collaborative programming with local community organizations, like the YMCA (eg, FUN2BFIT program) or the Boys & Girls Club, could be arranged. The inability to attain 26 hours should not deter patients or practitioners from participating in, referring to, or implementing obesity interventions. Rather, clinical teams and families should work together to maximize intervention dose using clinical and community programs synergistically. In the updated USPSTF recommendations, 4 ,5 there is a reinforcement to intervene at a young age when pediatric obesity is identified, with ILT recommended as early as age 6 years. Earlier intervention is better to establish healthy habits early in a child's development, 7 to intervene prior to puberty (when long-term cardiometabolic risk increases), 8 and to prevent psychosocial morbidity. 2 Establishing referrals to ILT at age 6 years as a standard of care has the potential for significant impact on weight trajectories of our nation's youth. However, evidence supports that weight patterns develop early in life, suggesting there could be benefit to starting interventions earlier than age 6 years. A prospective analysis of a population-based sample of 51 505 children found that approximately 90% of children who had obesity at age 3 years continued to have an elevated BMI in adolescence. 9 The greatest acceleration in BMI occurred -Abstract Truncated-
medicine, general & internal